$CAVA

CAVA GROUP, INC.

AlphAI earnings readFiscal Second Quarter 2026 · AUG 11 · NEXT NOV 4CAVA GROUP REPORTS SECOND QUARTER 2026 RESULTSVerdict: strong

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

0
0
1

No SEC Form 4 filings for $CAVA in the last 30 days.

See all $CAVA insider activity →
Low

UBS cuts Cava stock price target to $85 on near-term headwinds

UBS reduced its price target for Cava Group (NYSE:CAVA) to $85 from $90, citing near-term headwinds but maintaining a Buy rating. The stock has fallen over 43% in six months. UBS expects Q3 same-store sales near 3%, below consensus, with Q4 trends improving. Cava plans to open 75-77 new units in 2026. The company reported 27% revenue growth and $0.56 EPS over the last year. Other analysts have mixed views on the stock.

CAVA sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning CAVA (CAVA GROUP, INC.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.

Recent CAVA coverage spans financial news and corporate actions.

What's driving CAVA

AlphAI scores every news story that mentions CAVA with an AI model for sentiment and relevance, and aggregates insider trades from CAVA GROUP, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CAVA

Score
$CAVALow

UBS cuts Cava stock price target to $85 on near-term headwinds

UBS reduced its price target for Cava Group (NYSE:CAVA) to $85 from $90, citing near-term headwinds but maintaining a Buy rating. The stock has fallen over 43% in six months. UBS expects Q3 same-store sales near 3%, below consensus, with Q4 trends improving. Cava plans to open 75-77 new units in 2026. The company reported 27% revenue growth and $0.56 EPS over the last year. Other analysts have mixed views on the stock.

CAVA Group (CAVA) Targets 1,000 Locations By 2032

CAVA Group (NYSE:CAVA) has reached 500 US locations and plans to expand to 1,000 by 2032, focusing on the Midwest. Management highlights scale benefits but notes increased operational risks. Investors should watch 2026 Midwest openings for sales and margin performance.

Stocktwits Wall Street Wrap: Analysts Turn Bullish On Palantir, Marvell And Cava As Nike Faces Downgrade

Melius Research upgraded Cava (CAVA) to 'Buy' with a $95 target, citing long-term growth potential. Berenberg downgraded Nike (NKE) to 'Sell' with a $27.50 target, citing weaker sportswear demand. Oppenheimer downgraded Fiserv (FISV) to 'Perform' due to growth uncertainty. HSBC downgraded Constellation Brands (STZ) to 'Hold' with a $135 target, citing weak volume trends. Palantir (PLTR) and Marvell (MRVL) have seen gains this year.

Here Are Thursday’s Top Wall Street Analyst Research Calls: CAVA Group, Constellation Brands, Goldman Sachs Group, Hub Spot, Hut 8, Paladin Technologies, NXP Semiconductor, Spotify Technology, Tyler Technologies, and More

Wall Street analyst research calls include upgrades for CAVA Group, Chime Financial, Global Payments, Palantir, and Ryder Systems, with downgrades for Constellation Brands, HubSpot, Phillips 66, NXP Semiconductors, and Tyler Technologies. Initiations include Goldman Sachs, Hut 8, Nebius Group, Spotify, and TXO Partners. Markets fell Wednesday due to rising yields and oil prices, with Bitcoin also experiencing a sell-off.

$CAVAMed

Why Is CAVA Group (CAVA) Back In The Spotlight?

CAVA Group's board approved a $100M share repurchase program. The company's 30-day and 90-day share returns are down 22.77% and 35.84%, respectively, but 3-year total return is 71.56%. Analysts debate its valuation, with some seeing it as 36% undervalued at $83.72 fair value, while others note its high P/E ratio of 94.3x.

$CAVAMed

CAVA Unveils Share Repurchase

CAVA Group, Inc. (NYSE: CAVA) announced a $100 million share repurchase program, valid until September 17, 2027. The company may buy back shares in the open market or through private transactions, depending on market conditions and stock prices. Repurchases will be funded by existing cash and operational cash flows.

$CAVAMed

CAVA Unveils Share Repurchase

CAVA Group, Inc. (NYSE: CAVA) announced a share repurchase program, authorized to buy up to $100 million of its common stock. The program, valid until September 17, 2027, may be executed through open market purchases, private transactions, or other means. The company plans to fund repurchases with existing cash and operational cash flows.

Related tickers